For the past 30 years, umbilical cord blood has been a viable graft source option for hematopoietic cell transplant for both pediatric and adult patients with hematologic disorders.
The limited numbers of cord blood hematopoietic stem cells (HSCs) collected at birth remains a critical limiting factor in the use of cord blood for HSC transplantation.